Next Article in Journal
Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus
Next Article in Special Issue
Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy
Previous Article in Journal / Special Issue
The Mouse Papillomavirus Infection Model

Epigenetic Alterations in Human Papillomavirus-Associated Cancers

Division of Infectious Disease, Department of Medicine, Brigham & Women’s Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
Author to whom correspondence should be addressed.
Academic Editors: Alison A. McBride and Karl Munger
Viruses 2017, 9(9), 248;
Received: 14 August 2017 / Revised: 25 August 2017 / Accepted: 25 August 2017 / Published: 1 September 2017
(This article belongs to the Special Issue Expert Views on HPV Infection)
Approximately 15–20% of human cancers are caused by viruses, including human papillomaviruses (HPVs). Viruses are obligatory intracellular parasites and encode proteins that reprogram the regulatory networks governing host cellular signaling pathways that control recognition by the immune system, proliferation, differentiation, genomic integrity, and cell death. Given that key proteins in these regulatory networks are also subject to mutation in non-virally associated diseases and cancers, the study of oncogenic viruses has also been instrumental to the discovery and analysis of many fundamental cellular processes, including messenger RNA (mRNA) splicing, transcriptional enhancers, oncogenes and tumor suppressors, signal transduction, immune regulation, and cell cycle control. More recently, tumor viruses, in particular HPV, have proven themselves invaluable in the study of the cancer epigenome. Epigenetic silencing or de-silencing of genes can have cellular consequences that are akin to genetic mutations, i.e., the loss and gain of expression of genes that are not usually expressed in a certain cell type and/or genes that have tumor suppressive or oncogenic activities, respectively. Unlike genetic mutations, the reversible nature of epigenetic modifications affords an opportunity of epigenetic therapy for cancer. This review summarizes the current knowledge on epigenetic regulation in HPV-infected cells with a focus on those elements with relevance to carcinogenesis. View Full-Text
Keywords: Human papillomavirus; HPV; cervical cancer; epigenetics; histone Human papillomavirus; HPV; cervical cancer; epigenetics; histone
Show Figures

Figure 1

MDPI and ACS Style

Soto, D.; Song, C.; McLaughlin-Drubin, M.E. Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses 2017, 9, 248.

AMA Style

Soto D, Song C, McLaughlin-Drubin ME. Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses. 2017; 9(9):248.

Chicago/Turabian Style

Soto, David; Song, Christine; McLaughlin-Drubin, Margaret E. 2017. "Epigenetic Alterations in Human Papillomavirus-Associated Cancers" Viruses 9, no. 9: 248.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop